Literature DB >> 21934326

Serum vitamin D level and prehypertension among subjects free of hypertension.

Charumathi Sabanayagam1, Anoop Shankar, Shanmugasundaram Somasundaram.   

Abstract

BACKGROUND: Low serum vitamin D levels are associated with high blood pressure (BP). Prehypertension is a preclinical stage where primary prevention efforts have been recommended for delaying or preventing the onset of hypertension. However, the majority of studies examining the association between vitamin D and BP have not accounted for kidney function or systemic inflammation.
METHODS: Participants of the 3rd National Health and Nutrition Examination Survey > 20 years of age and free of hypertension (n = 9,215, 53.5% women) and clinical cardiovascular disease were examined. Serum vitamin D levels were analyzed as quartiles. Prehypertension (n = 3,712) was defined as systolic BP 120-139 mm Hg or diastolic BP 80-89 mm Hg.
RESULTS: Lower serum vitamin D levels were found to be associated with prehypertension independent of potential confounders including body mass index (BMI), serum cholesterol, C-reactive protein and estimated glomerular filtration rate. Compared to the highest quartile of serum vitamin D (referent), the odds ratio (95% confidence interval) of prehypertension associated with the lowest quartile was 1.48 (1.16-1.90; p trend < 0.0001). This association persisted in subgroup analyses by gender, race-ethnicity and BMI.
CONCLUSION: Lower serum vitamin D levels are associated with prehypertension in a representative sample of US adults.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934326      PMCID: PMC3221248          DOI: 10.1159/000330716

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  36 in total

Review 1.  The impact of vitamin D deficiency on diabetes and cardiovascular risk.

Authors:  Merav Baz-Hecht; Allison B Goldfine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-04       Impact factor: 3.243

2.  Suppression of renin-angiotensin gene expression in the kidney by paricalcitol.

Authors:  Michael Freundlich; Yasmir Quiroz; Zhongyi Zhang; Yan Zhang; Yanauri Bravo; Jose R Weisinger; Yan Chun Li; Bernardo Rodriguez-Iturbe
Journal:  Kidney Int       Date:  2008-08-27       Impact factor: 10.612

3.  Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men.

Authors:  David M Lee; Martin K Rutter; Terence W O'Neill; Steven Boonen; Dirk Vanderschueren; Roger Bouillon; Gyorgy Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Alan J Silman; Frederick C W Wu
Journal:  Eur J Endocrinol       Date:  2009-09-22       Impact factor: 6.664

4.  Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans.

Authors:  Kimberly J Schmitz; Halcyon G Skinner; Leonelo E Bautista; Tasha E Fingerlin; Carl D Langefeld; Pamela J Hicks; Steven M Haffner; Michael Bryer-Ash; Lynne E Wagenknecht; Donald W Bowden; Jill M Norris; Corinne D Engelman
Journal:  Am J Hypertens       Date:  2009-05-14       Impact factor: 2.689

5.  Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.

Authors:  Karen L Margolis; Roberta M Ray; Linda Van Horn; Joann E Manson; Matthew A Allison; Henry R Black; Shirley A A Beresford; Stephanie A Connelly; J David Curb; Richard H Grimm; Theodore A Kotchen; Lewis H Kuller; Sylvia Wassertheil-Smoller; Cynthia A Thomson; James C Torner
Journal:  Hypertension       Date:  2008-09-29       Impact factor: 10.190

Review 6.  Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?

Authors:  John H Lee; James H O'Keefe; David Bell; Donald D Hensrud; Michael F Holick
Journal:  J Am Coll Cardiol       Date:  2008-12-09       Impact factor: 24.094

7.  Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension.

Authors:  Rolf Jorde; Yngve Figenschau; Nina Emaus; Moira Hutchinson; Guri Grimnes
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

8.  Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women.

Authors:  John P Forman; Gary C Curhan; Eric N Taylor
Journal:  Hypertension       Date:  2008-10-06       Impact factor: 10.190

9.  Vitamin D status and health correlates among German adults.

Authors:  B Hintzpeter; G B M Mensink; W Thierfelder; M J Müller; C Scheidt-Nave
Journal:  Eur J Clin Nutr       Date:  2007-05-30       Impact factor: 4.016

10.  Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro.

Authors:  Y Talmor; J Bernheim; O Klein; J Green; G Rashid
Journal:  Eur J Clin Invest       Date:  2008-08       Impact factor: 4.686

View more
  6 in total

Review 1.  Does vitamin D modulate blood pressure?

Authors:  Hector Tamez; Sahir Kalim; Ravi I Thadhani
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

Review 2.  Vitamin D and cardiovascular risk.

Authors:  Shweta R Motiwala; Thomas J Wang
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 3.  Vitamin D deficiency and essential hypertension.

Authors:  Songcang Chen; Yingxian Sun; Devendra K Agrawal
Journal:  J Am Soc Hypertens       Date:  2015-08-21

Review 4.  Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

Authors:  Federico Carbone; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  World J Cardiol       Date:  2014-05-26

5.  Serum Vitamin D Levels in Relation to Hypertension and Pre-hypertension in Adults: A Systematic Review and Dose-Response Meta-Analysis of Epidemiologic Studies.

Authors:  Elahe Mokhtari; Zahra Hajhashemy; Parvane Saneei
Journal:  Front Nutr       Date:  2022-03-10

6.  Vitamin D Deficiency Is a Potential Risk for Blood Pressure Elevation and the Development of Hypertension.

Authors:  Yusuf Karadeniz; Fatma Özpamuk-Karadeniz; Süleyman Ahbab; Esra Ataoğlu; Günay Can
Journal:  Medicina (Kaunas)       Date:  2021-11-25       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.